Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity while testing the below finished product batches manufactured utilizing active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited using the old Route of Synthesis.
source https://www.pharmatutor.org/pharma-news/2019/torrent-pharma-expanding-its-recall-for-losartan-potassium-tablets
No comments:
Post a Comment